ArticleACS synthetic biology2026
Impact of Reducing Agents on Protein Synthesis in a Reconstituted Cell-Free Protein Synthesis System.
Article in ACS synthetic biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining proper redox conditions is essential for protein stability and function. In cell-free protein synthesis, reducing agents, such as dithiothreitol and reduced glutathione, are commonly added to mimic the cytosolic environment and prevent unwanted oxidation. The PURE system, which is a fully reconstituted protein synthesis system, also contains reducing agents. Here, we systematically examined how reducing agents affect the protein synthesis in the PURE system. We found that the reducing activity of dithiothreitol decreased during prolonged reactions, leading to the formation of disulfide bonds in synthesized proteins. Dissolved oxygen and contaminating metal ions were identified as major factors causing this loss of activity. Based on these findings, we developed a method to maintain reducing conditions throughout the reaction, ensuring consistent protein quality. Our results provide new insights into redox regulation in cell-free systems and offer a practical strategy for the efficient synthesis of functional proteins, with potential applications in biotechnology and therapeutic protein production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.